Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand
Authors:
- Zaheer-Ud-Din BabarZBZaheer-Ud-Din Babar
- Piyush GroverPGPiyush Grover
- Joanna StewartJSJoanna Stewart
- Michele HoggMHMichele Hogg
- Leanne ShortLSLeanne Short
- Hee Gyung SeoHSHee Gyung Seo
- Anne RewARAnne Rew
- 1 September 2011
- journal article
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 7 (3) , 294-305
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- How New Zealand has contained expenditure on drugsBMJ, 2010
- Prescription drug subsidies in Australia and New ZealandAustralian Prescriber, 2010
- Pharmaceutical brand substitution in Australia – are there multiple switches per prescription?Australian and New Zealand Journal of Public Health, 2007
- Do generics offer significant savings to the UK National Health Service?Current Medical Research and Opinion, 2006
- Patients’ attitudes towards and experiences of generic drug substitution in NorwayPharmacy World & Science, 2006
- The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugsClinical Therapeutics, 2003
- Exploring Generic Drug Use BehaviorMedical Care, 2002
- Generic medicines are not substandard medicines.The Lancet, 2002
- Generic Drugs: Consumer, Pharmacist and Physician Perceptions of the IssuesJournal of Consumer Affairs, 1980
- Physician and pharmacist perceptions of generic drugsIndustrial Marketing Management, 1979